Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?

This publication has 46 references indexed in Scilit:

• Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate
  Carcinogenesis: Integrative Cancer Research, 2002
• Brain-tumour drug resistance: the bare essentials
  The Lancet Oncology, 2002
• Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer
  Breast Cancer Research, 2002
• Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cells
  The Esophagus, 2002
• Resistance to cytotoxic agents.
  Current Opinion in Pharmacology, 2001
• Anticancer drug resistance in primary human brain tumors
  Brain Research Reviews, 2001
• Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance
  Oncogene, 2001
• Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
  New England Journal of Medicine, 2000
• Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo
  Acta Neuropathologica, 2000
• Expression of neu/c-erbB-2 in human brain tumors
  Human Pathology, 1994